CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 55 enrolled
Drug / intervention
Intraarticular platelet rich plasma cervical facet injection +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04392999
NCT04392999Phase 3Completed

A Pilot Study Comparing Intra-articular Corticosteroid Injections to Platelet Rich Plasma (PRP) as a Treatment for Cervical Facetogenic Pain

In Brief

A Phase 3 clinical trial evaluating Intraarticular platelet rich plasma cervical facet injection and Corticosteroid injection for Cervical Pain. Completed, enrolled 55 participants across 1 site.

Detailed Summary

Chronic neck pain, either after trauma (e.g. whiplash injury) or due to arthritis, is a significant issue for many Canadians. Steroid injections into the small joints of the neck can provide temporary pain relief, but patients require repeat injections every few months. The investigator will assess whether a different type of injection (platelet-rich plasma, PRP) can provide enhanced and longer-lasting pain relief compared to steroid. PRP is made from the patient's own blood but contains higher levels of components that promote healing. Patients with neck pain will receive either an injection of steroid or PRP into the small joints of the neck, but they won't know which one they are getting. After the injection they will be contacted to answer questions about their pain and function, up to 12 months after injection. The goal of this study is to determine if PRP is a viable alternative to current treatments to help reduce chronic neck pain and improve function after a whiplash injury. PRP may be a more permanent treatment for chronic neck pain which could reduce the need for repeated injections, thus reducing health care costs and wait times.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Pain
CountriesCanada
Collaborators--

Timeline

Phase 3CompletedFinished
202120222023202420252026
First PostedMay 19, 2020
Enrollment StartFeb 1, 2021
Primary CompletionMar 26, 2023
Study CompletionAug 15, 2024
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 6.1 years ago

Interventions

Intraarticular platelet rich plasma cervical facet injectiondrug

Injection of PRP into the cervical facet joints.

Corticosteroid injectiondrug

Injection of corticosteroid into the cervical facet joints.